Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma

Yohei Mano; Shinichi Aishima; Yuichiro Kubo; Yuki Tanaka; Takashi Motomura; Takeo Toshima; Ken Shirabe; Shingo Baba; Yoshihiko Maehara; Yoshinao Oda

doi:10.1309/AJCPG8AFJ5NRKLLM

Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma

Yohei Mano, Shinichi Aishima, Yuichiro Kubo, Yuki Tanaka, Takashi Motomura, Takeo Toshima, Ken Shirabe, Shingo Baba, Yoshihiko Maehara, Yoshinao Oda

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Objectives: This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients with hepatocellular carcinoma.

Methods: Forty-two patients with hepatocellular carcinoma who underwent FDG positron emission tomography were included in the study. Tumor sections were immunohistochemically stained for phosphorylated signal transducer and activator of transcription 3 (pSTAT3), hypoxia-inducible factor 1α (HIF1α), glucose transporter 1 (GLUT1), GLUT2, GLUT3, and GLUT4.

Results: The high standardized uptake value (SUV) group showed larger tumor size, more frequent vascular invasion, and poorer differentiation compared with the low SUV group. The high SUV group also showed significantly higher immunohistochemical expression of pSTAT3, HIF1α, and GLUT1. The GLUT1 high-expression group showed higher α-fetoprotein (a tumor marker) and poorer differentiation than did the GLUT1 low-expression group.

Conclusions: Our study indicates that FDG uptake is associated with the expression of pSTAT3, HIF1α, and GLUT1 in hepatocellular carcinoma. The expression of these proteins shows a correlation with poor differentiation and vascular invasion.

Original language	English
Pages (from-to)	391-397
Number of pages	7
Journal	American Journal of Clinical Pathology
Volume	142
Issue number	3
DOIs	https://doi.org/10.1309/AJCPG8AFJ5NRKLLM
Publication status	Published - Sep 1 2014

All Science Journal Classification (ASJC) codes

Pathology and Forensic Medicine

Access to Document

10.1309/AJCPG8AFJ5NRKLLM

Fingerprint Dive into the research topics of 'Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this

Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma. / Mano, Yohei; Aishima, Shinichi; Kubo, Yuichiro; Tanaka, Yuki; Motomura, Takashi; Toshima, Takeo; Shirabe, Ken; Baba, Shingo; Maehara, Yoshihiko; Oda, Yoshinao.

In: American Journal of Clinical Pathology, Vol. 142, No. 3, 01.09.2014, p. 391-397.

Research output: Contribution to journal › Article › peer-review

Mano, Yohei ; Aishima, Shinichi ; Kubo, Yuichiro ; Tanaka, Yuki ; Motomura, Takashi ; Toshima, Takeo ; Shirabe, Ken ; Baba, Shingo ; Maehara, Yoshihiko ; Oda, Yoshinao. / Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma. In: American Journal of Clinical Pathology. 2014 ; Vol. 142, No. 3. pp. 391-397.

@article{b40a2af7134044b7b5f14637ffc95020,

title = "Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma",

abstract = "Objectives: This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients with hepatocellular carcinoma.Methods: Forty-two patients with hepatocellular carcinoma who underwent FDG positron emission tomography were included in the study. Tumor sections were immunohistochemically stained for phosphorylated signal transducer and activator of transcription 3 (pSTAT3), hypoxia-inducible factor 1α (HIF1α), glucose transporter 1 (GLUT1), GLUT2, GLUT3, and GLUT4.Results: The high standardized uptake value (SUV) group showed larger tumor size, more frequent vascular invasion, and poorer differentiation compared with the low SUV group. The high SUV group also showed significantly higher immunohistochemical expression of pSTAT3, HIF1α, and GLUT1. The GLUT1 high-expression group showed higher α-fetoprotein (a tumor marker) and poorer differentiation than did the GLUT1 low-expression group.Conclusions: Our study indicates that FDG uptake is associated with the expression of pSTAT3, HIF1α, and GLUT1 in hepatocellular carcinoma. The expression of these proteins shows a correlation with poor differentiation and vascular invasion.",

author = "Yohei Mano and Shinichi Aishima and Yuichiro Kubo and Yuki Tanaka and Takashi Motomura and Takeo Toshima and Ken Shirabe and Shingo Baba and Yoshihiko Maehara and Yoshinao Oda",

year = "2014",

month = sep,

day = "1",

doi = "10.1309/AJCPG8AFJ5NRKLLM",

language = "English",

volume = "142",

pages = "391--397",

journal = "American Journal of Clinical Pathology",

issn = "0002-9173",

publisher = "American Society of Clinical Pathologists",

number = "3",

}

TY - JOUR

T1 - Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma

AU - Mano, Yohei

AU - Aishima, Shinichi

AU - Kubo, Yuichiro

AU - Tanaka, Yuki

AU - Motomura, Takashi

AU - Toshima, Takeo

AU - Shirabe, Ken

AU - Baba, Shingo

AU - Maehara, Yoshihiko

AU - Oda, Yoshinao

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Objectives: This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients with hepatocellular carcinoma.Methods: Forty-two patients with hepatocellular carcinoma who underwent FDG positron emission tomography were included in the study. Tumor sections were immunohistochemically stained for phosphorylated signal transducer and activator of transcription 3 (pSTAT3), hypoxia-inducible factor 1α (HIF1α), glucose transporter 1 (GLUT1), GLUT2, GLUT3, and GLUT4.Results: The high standardized uptake value (SUV) group showed larger tumor size, more frequent vascular invasion, and poorer differentiation compared with the low SUV group. The high SUV group also showed significantly higher immunohistochemical expression of pSTAT3, HIF1α, and GLUT1. The GLUT1 high-expression group showed higher α-fetoprotein (a tumor marker) and poorer differentiation than did the GLUT1 low-expression group.Conclusions: Our study indicates that FDG uptake is associated with the expression of pSTAT3, HIF1α, and GLUT1 in hepatocellular carcinoma. The expression of these proteins shows a correlation with poor differentiation and vascular invasion.

AB - Objectives: This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients with hepatocellular carcinoma.Methods: Forty-two patients with hepatocellular carcinoma who underwent FDG positron emission tomography were included in the study. Tumor sections were immunohistochemically stained for phosphorylated signal transducer and activator of transcription 3 (pSTAT3), hypoxia-inducible factor 1α (HIF1α), glucose transporter 1 (GLUT1), GLUT2, GLUT3, and GLUT4.Results: The high standardized uptake value (SUV) group showed larger tumor size, more frequent vascular invasion, and poorer differentiation compared with the low SUV group. The high SUV group also showed significantly higher immunohistochemical expression of pSTAT3, HIF1α, and GLUT1. The GLUT1 high-expression group showed higher α-fetoprotein (a tumor marker) and poorer differentiation than did the GLUT1 low-expression group.Conclusions: Our study indicates that FDG uptake is associated with the expression of pSTAT3, HIF1α, and GLUT1 in hepatocellular carcinoma. The expression of these proteins shows a correlation with poor differentiation and vascular invasion.

UR - http://www.scopus.com/inward/record.url?scp=84907178632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907178632&partnerID=8YFLogxK

U2 - 10.1309/AJCPG8AFJ5NRKLLM

DO - 10.1309/AJCPG8AFJ5NRKLLM

M3 - Article

C2 - 25125631

AN - SCOPUS:84907178632

VL - 142

SP - 391

EP - 397

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -